Discovering New Treatments for Rare Genetic Diseases with Modelis CEO and Co-Founder James Doyle

ONCE UPON A GENE - EPISODE 089
Discovering New Treatments for Rare Genetic Diseases with Modelis CEO and Co-Founder James Doyle

Exposed first hand to research of genetic diseases and the lack of information known, my guest quickly realized the need to streamline the process of translating genetic data into therapeutic discoveries. James Doyle is the Co-Founder and CEO of Modelis whose mission is to rapidly advance personalized drug discovery for rare genetic diseases.

EPISODE HIGHLIGHTS

What is your background and what drew you to this field of research?
I'm a scientist by training, but an entrepreneur by spirit. My background is in molecular genetics and I like to understand how genes work, what they do and how mutations of genes influence function and lead to a disease. Along with a couple of colleagues, Modelis was founded which is a biotech company that does drug screening and translational drug discovery for rare genetic disorders using small animal models to accelerate the process.

What is translational drug discovery?
It's the bench to bedside approach of taking findings from a lab to a clinical, real world setting where they can have a real world impact.

What is the process for a patient organization or advocacy group who is seeking research?
An initial feasibility study is conducted on small animal models to see if the gene is a good candidate for the models. Genetic avatars of the patients are created with worms using genetic engineering techniques. The animals are used to better study the disorder, the underlying causes of the disease and drug screening. The worms are used to rapidly discover drugs with a high translational potential. The next step is to validate the findings in zebra fish and then potentially a rodent model to further validate drugs.

How does Modelis help to accelerate research?
For a lot of disorders, it's rarely a one-size-fits-all equation. Research can be accelerated through leveraging different approaches in a complimentary manner, like exploring drug repurposing with small animal models while also pursuing gene therapy.

What is the cost for a patient organization who is seeking drug research?
It depends, but it's a customized approach based on each specific disorder. We work with groups through venture philanthropy or social impact investing and strive for collaborative wins that can be shared back with the community who initiated the research.
LINKS AND RESOURCES MENTIONED
Once Upon Gene TV - Disorder Channel
thedisordercollection.com/" target="_blank" rel="noopener noreferrer">https://www.thedisordercollection.com/

CONNECT WITH MODELIS
Modelis Website
https://modelis.ca/
Modelis on Twitter
https://twitter.com/ModelisLabs
Modelis on Facebook
facebook.com/ModelisLabs/" target="_blank" rel="noopener noreferrer">https://www.facebook.com/ModelisLabs/
Modelis on LinkedIn
linkedin.com/company/modelis-inc" target="_blank" rel="noopener noreferrer">https://ca.linkedin.com/company/modelis-inc

TUNE INTO THE ONCE UPON A GENE PODCAST
Spotify
spotify.com/show/5Htr9lt5vXGG3ac6enxLQ7" target="_blank" rel="noopener noreferrer">https://open.spotify.com/show/5Htr9lt5vXGG3ac6enxLQ7
Apple Podcasts
apple.com/us/podcast/once-upon-a-gene/id1485249347" target="_blank" rel="noopener noreferrer">https://podcasts.apple.com/us/podcast/once-upon-a-gene/id1485249347
Stitcher
stitcher.com/podcast/once-upon-a-gene" target="_blank" rel="noopener noreferrer">https://www.stitcher.com/podcast/once-upon-a-gene
Overcast
https://overcast.fm/itunes1485249347/once-upon-a-gene

CONNECT WITH EFFIE PARKS
Website
https://effieparks.com/
Twitter
https://twitter.com/OnceUponAGene
Instagram
instagram.com/onceuponagene.podcast/?hl=en" target="_blank" rel="noopener noreferrer">https://www.instagram.com/onceuponagene.podcast/?hl=en
Built Ford Tough Facebook Group
facebook.com/groups/1877643259173346/" target="_blank" rel="noopener noreferrer">https://www.facebook.com/groups/1877643259173346/